Product NDC: | 0832-0230 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | Morphine Sulfate |
Active Ingredient(s): | 80 mg/1 & nbsp; Morphine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0832-0230 |
Labeler Name: | Upsher-Smith Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202104 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130630 |
Package NDC: | 0832-0230-00 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0230-00) |
NDC Code | 0832-0230-00 |
Proprietary Name | Morphine Sulfate |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0230-00) |
Product NDC | 0832-0230 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Morphine Sulfate |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130630 |
Marketing Category Name | ANDA |
Labeler Name | Upsher-Smith Laboratories, Inc. |
Substance Name | MORPHINE SULFATE |
Strength Number | 80 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |